NCT05015348

Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients with Hyperlipidemia

Effects of Omega-3 Polyenoic Acid on Blood Lipid, Inflammatory Factors and Body Composition in Patients with Hyperlipidemia

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Peking Union Medical College Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Patients with hyperlipidemia will be allocated into intervention or control group randomly. Participants of intervention group will be provided with Omega-3 PUFA, while participants of control group will be provided with placebo which looked same as the drug of intervention group. During the study, all participants can have nutritional counseling and education for low-fat diet. The lipids, inflammatory factors, weight, and body composition will be assessed and recorded before, at the middle, and end of the study.

Detailed description

Randomization tables were generated by the statistician and provided to the investigational pharmacist who distributed the blinded pills to participants. Participants of intervention group will be provided with Omega-3 PUFA, while participants of control group will be provided with placebo which looked same as the drug of intervention group. During the study, all participants can have nutritional counseling and education for low-fat diet. The lipids, inflammatory factors, weight, and body composition will be assessed and recorded before, at the middle, and end of the study.

Conditions

• Hyperlipidemias

Interventions

Type	Name	Description
OTHER	fish oil with omega-3 PUFA	3.6g per day fish oil with omega-3 PUFA (EPA+DHA)
OTHER	placebo	palm oil as placebo

Timeline

• Start date: 2021-12-01
• Primary completion: 2024-03-01
• Completion: 2024-12-31
• First posted: 2021-08-20
• Last updated: 2025-01-01

Locations

1 site across 1 country: China